Categories: International

US begun phase one clinical Human trial of coronavirus vaccine

The United State has begun phase one of the clinical Human trial of an investigational vaccine designed to protect against the coronavirus disease which has claimed the lives of over 7,000 people globally.

Important Facts of Covid-19 vaccine trial:

  • The trial began at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle as the first participant received the investigational vaccine.
  • The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is funding the trial.
  • The open-label trial will enrol 45 healthy adult volunteers aged 18 to 55 years over approximately six weeks.
  • The study participants will receive two doses of the vaccine via intramuscular injection in the upper arm approximately 28 days apart.
  • The vaccine is called mRNA-1273 and was developed by the NIAID scientists and their collaborators at the biotechnology company Moderna, Inc., based in Cambridge, Massachusetts.
  • The Coalition for Epidemic Preparedness Innovations (CEPI) supported the manufacturing of the vaccine candidate for the Phase 1 clinical trial. CEPI so far has secured USD 760 million toward its USD 1 billion funding target, with multi-year funding from Norway, the UK, Germany, Japan, Canada, Ethiopia, Australia, the Bill & Melinda Gates Foundation, and Wellcome.
  • The CEPI set up to accelerate the development of vaccines against emerging infectious diseases, made an urgent call for USD 2 billion to support the development of a vaccine against the virus responsible for COVID-19.

Important takeaways for all competitive exams:

  • COVID-19 cases were first identified in December 2019 in China’s Wuhan in Hubei province. As of March 15, the WHO has reported 153,517 cases of COVID-19 and 5,735 deaths worldwide.

Find More International News

Sumit Arora

As a team lead and current affairs writer at Adda247, I am responsible for researching and producing engaging, informative content designed to assist candidates in preparing for national and state-level competitive government exams. I specialize in crafting insightful articles that keep aspirants updated on the latest trends and developments in current affairs. With a strong emphasis on educational excellence, my goal is to equip readers with the knowledge and confidence needed to excel in their exams. Through well-researched and thoughtfully written content, I strive to guide and support candidates on their journey to success.

Recent Posts

National Book Awards 2026: Hannah Lillith Assadi Wins Fiction Prize for Paradiso 17

Hannah Lillith Assadi, a Palestinian-Jewish writer, has won the National Book Award for Fiction for…

28 minutes ago

AI Kavach: IIT Kanpur and Bharat1.ai Launch AI Cybersecurity Lab for Financial Sector

AI Kavach is a cybersecurity and assurance laboratory developed in collaboration between IIT Kanpur and…

1 hour ago

Rani Lakshmibai Birth Anniversary 2026: Life, Revolt of 1857 and Legacy

Rani of Jhansi was an important figure in the Revolt of 1857. Rani Lakshmibai was…

2 hours ago

World Toilet Day 2026: Theme, History, Significance and India’s Sanitation Initiatives

World Toilet Day 2026 takes place on the 19th November. It aims to highlight how…

3 hours ago

International Men’s Day 2026: Date, History, Theme and Significance

International Men’s Day takes place every year on 19th of the November. 2026’s theme is…

3 hours ago

Indira Gandhi Birth Anniversary 2026: Early Life, Education, Political Career and Major Contributions

Indira Priyadarshini Gandhi was born on 19th November 1917. She held the position of Prime…

3 hours ago